You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

16 June 2017

One in three people with HIV start treatment late in low- and middle-income countries

World Health Organization (WHO) guidelines call for all people newly diagnosed to start treatment straight away – but worrying numbers of people in high-burden countries still test and present late to care.

13 June 2017

Cryptococcal meningitis remains a leading killer of people living with HIV

First update on cryptococcus in the era of antiretroviral treatment expansion reveals disproportionate burden in sub-Saharan Africa and a need for better treatment options.

02 June 2017

People living with HIV have increased risk of neurocognitive impairment when they grow older

In the era of highly active antiretroviral treatment, HIV-associated neurocognitive disorders (HAND) still affect people living with HIV as they get older

23 May 2017

‘Global Gag’ threatens plans to improve women’s access to HIV services

HIV is the leading cause of death for women of reproductive age and Washington-led health policies show a lack of understanding of the realities and importance of health service integration on the ground.

15 May 2017

Life expectancy for people with HIV is now near-normal – but only for those accessing treatment

There has been a vast decline in mortality among people with HIV who get on antiretroviral treatment – but who are we leaving behind?

31 March 2017

Asia performs better than Africa in keeping people adhering to HIV treatment

Weaker health systems and psychosocial factors may explain the differences in adherence patterns between Asia and Africa, the world’s two most HIV-affected regions.

21 February 2017

Pre-treatment drug resistance as high as 17% with no impact on viral load suppression

‘Surprising’ research from Conference on Retroviruses and Opportunistic Infections (CROI) shows drug resistance does not impact test-and-treat roll-out in South Africa – at least in the short term.

16 February 2017

Strong trial results and high resistance barrier for integrase inhibitor treatment put Gilead on path to new HIV drug

Drug trial results for new integrase inhibitor show promising viral suppression rates.

27 January 2017

Discovery of chemical messages between viruses could provide new way to induce HIV latency

One of the first studies into viral communication shows that viruses that infect bacteria (phages) leave chemical messages for each other which help them decide whether to kill or linger. Disrupting these messages could provide a new way to control HIV.

25 January 2017

11 things to expect from an HIV home-test

HIV home-testing kits are available in a growing number of countries. They offer you the convenience of taking an HIV test in your own time and in the privacy of your own home – but are they for everyone?